BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30872479)

  • 1. Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1.
    Lückmann M; Trauelsen M; Bentsen MA; Nissen TAD; Martins J; Fallah Z; Nygaard MM; Papaleo E; Lindorff-Larsen K; Schwartz TW; Frimurer TM
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7123-7128. PubMed ID: 30872479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.
    Srivastava A; Yano J; Hirozane Y; Kefala G; Gruswitz F; Snell G; Lane W; Ivetac A; Aertgeerts K; Nguyen J; Jennings A; Okada K
    Nature; 2014 Sep; 513(7516):124-7. PubMed ID: 25043059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics.
    Atanasio S; Deganutti G; Reynolds CA
    J Comput Aided Mol Des; 2020 Nov; 34(11):1181-1193. PubMed ID: 32851580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1.
    Yabuki C; Komatsu H; Tsujihata Y; Maeda R; Ito R; Matsuda-Nagasumi K; Sakuma K; Miyawaki K; Kikuchi N; Takeuchi K; Habata Y; Mori M
    PLoS One; 2013; 8(10):e76280. PubMed ID: 24130766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40.
    Lu J; Byrne N; Wang J; Bricogne G; Brown FK; Chobanian HR; Colletti SL; Di Salvo J; Thomas-Fowlkes B; Guo Y; Hall DL; Hadix J; Hastings NB; Hermes JD; Ho T; Howard AD; Josien H; Kornienko M; Lumb KJ; Miller MW; Patel SB; Pio B; Plummer CW; Sherborne BS; Sheth P; Souza S; Tummala S; Vonrhein C; Webb M; Allen SJ; Johnston JM; Weinglass AB; Sharma S; Soisson SM
    Nat Struct Mol Biol; 2017 Jul; 24(7):570-577. PubMed ID: 28581512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free fatty acid receptors: structural models and elucidation of ligand binding interactions.
    Tikhonova IG; Poerio E
    BMC Struct Biol; 2015 Sep; 15():16. PubMed ID: 26346819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for GPR40 allosteric agonism and incretin stimulation.
    Ho JD; Chau B; Rodgers L; Lu F; Wilbur KL; Otto KA; Chen Y; Song M; Riley JP; Yang HC; Reynolds NA; Kahl SD; Lewis AP; Groshong C; Madsen RE; Conners K; Lineswala JP; Gheyi T; Saflor MD; Lee MR; Benach J; Baker KA; Montrose-Rafizadeh C; Genin MJ; Miller AR; Hamdouchi C
    Nat Commun; 2018 Apr; 9(1):1645. PubMed ID: 29695780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Insights into Molecular Activation and Positive Cooperative Mechanisms of FFAR1 Modulators.
    Teng D; Chen J; Li D; Wu Z; Li W; Tang Y; Liu G
    J Chem Inf Model; 2020 Jun; 60(6):3214-3230. PubMed ID: 32338509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generating thermostabilized agonist-bound GPR40/FFAR1 using virus-like particles and a label-free binding assay.
    Hirozane Y; Motoyaji T; Maru T; Okada K; Tarui N
    Mol Membr Biol; 2014 Aug; 31(5):168-75. PubMed ID: 25068810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs.
    Hollingsworth SA; Kelly B; Valant C; Michaelis JA; Mastromihalis O; Thompson G; Venkatakrishnan AJ; Hertig S; Scammells PJ; Sexton PM; Felder CC; Christopoulos A; Dror RO
    Nat Commun; 2019 Jul; 10(1):3289. PubMed ID: 31337749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
    Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
    ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.
    Hui WQ; Cheng Q; Liu TY; Ouyang Q
    J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.
    Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
    J Mol Graph Model; 2015 Jul; 60():1-14. PubMed ID: 26080355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An allosteric modulator binds to a conformational hub in the β
    Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P
    Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of intracellular allosteric β
    Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
    Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for GPCR signaling by small polar versus large lipid metabolites-discovery of non-metabolite ligands.
    Lückmann M; Trauelsen M; Frimurer TM; Schwartz TW
    Curr Opin Cell Biol; 2020 Apr; 63():38-48. PubMed ID: 31951921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.